Clinical trial
Autologous Chondrocyte Implantation in the Patellofemoral Joint
NCT00212849 · Orthopaedic Research Foundation, Other · Completed
Key facts
| NCT number | NCT00212849 |
|---|---|
| Title | Autologous Chondrocyte Implantation in the Patellofemoral Joint |
| Official title | Autologous Chondrocyte Implantation in the Patellofemoral Joint |
| Lead sponsor | Orthopaedic Research Foundation, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Chondrosis, Patellar Articular Cartilage Lesions, Trochlear Articular Cartilage Lesions |
| Enrollment | 35 |
| Start date | Jan 1, 1995 |
| Completion | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: